{"id":559603,"date":"2021-01-27T03:45:13","date_gmt":"2021-01-27T03:45:13","guid":{"rendered":"https:\/\/enterpriseam.com\/egypt\/2021\/01\/27\/landmark-ma-in-pharma-education\/"},"modified":"2021-01-27T03:45:13","modified_gmt":"2021-01-27T03:45:13","slug":"landmark-ma-in-pharma-education","status":"publish","type":"post","link":"https:\/\/enterpriseam.com\/egypt\/2021\/01\/27\/landmark-ma-in-pharma-education\/","title":{"rendered":"Landmark M&A in pharma, education"},"content":{"rendered":"

<\/a> The week ends with news of two landmark acquisitions<\/strong>, one each in pharma and education.<\/p>\n

LSE-listed <\/strong>Hikma Pharma<\/a><\/strong> plans to buy a 91.2% stake in GlaxoSmithKline\u2019s pharma <\/strong>and manufacturing business in Egypt<\/strong>, according to an EGX disclosure (pdf)<\/a>. The transaction would be subject to the completion of due diligence \u2014 which GSK\u2019s board must now approve \u2014 as well as regulatory approvals, and would take place following Hikma\u2019s submission of a mandatory purchase offer of 100% of GSK\u2019s Egyptian arm. The non-binding term sheet signed by both companies also includes a potential acquisition of GSK\u2019s Tunisia business. A timeline for the acquisition, or the potential value of the purchase were not disclosed. Reuters<\/a> also took note of the story.<\/p>\n

ALSO- We have the first education acquisition since the ministry <\/strong>lifted the 20% foreign<\/a><\/strong><\/a><\/strong>ownership cap<\/a><\/strong>:<\/strong> Mauritius-based Olympus Victory has acquired Al Rowad International School for an undisclosed sum, advisors Matouk Bassiouny & Hennawy announced in a statement (pdf)<\/a> yesterday. Olympus is the foreign shareholder and owner of Kaumeya Language Schools. Matouk Bassiouny\u2019s Islam Saeed (partner and head of the education group) led the transaction with an assist from associate Yara Ghoneim.<\/p>\n

WAT<\/strong>CH THIS SPACE- SFE + ADQ announcing new investments this quarter:<\/strong> The USD 20 bn investment platform Egypt and the UAE set up back in 2019<\/a> through the Sovereign Fund of Egypt and ADQ (formerly known as Abu Dhabi Holding Company) will announce a number of new joint investments by the end of 1Q2021, Planning Minister Hala El Said in a statement<\/a> yesterday. El Said discussed the platform with SFE boss Ayman Soliman and ADQ Egypt CEO Mohamed Al Suwaidi.<\/p>\n","protected":false},"excerpt":{"rendered":"

The week ends with news of two landmark acquisitions, one each in pharma and education. LSE-listed Hikma Pharma plans to buy a 91.2% stake in GlaxoSmithKline\u2019s pharma and manufacturing business in Egypt, according to an EGX disclosure (pdf). The transaction would be subject to the completion of due diligence \u2014 which GSK\u2019s board must now […]<\/p>\n","protected":false},"author":1,"featured_media":559604,"comment_status":"closed","ping_status":"open","sticky":false,"template":"single-feature.php","format":"standard","meta":{"_acf_changed":false,"newspack_ads_suppress_ads":false,"newspack_popups_has_disabled_popups":false,"newspack_sponsor_sponsorship_scope":"","newspack_sponsor_native_byline_display":"inherit","newspack_sponsor_native_category_display":"inherit","newspack_sponsor_underwriter_style":"inherit","newspack_sponsor_underwriter_placement":"inherit","ep_exclude_from_search":false,"_primary_brand":0,"newspack_featured_image_position":"","newspack_post_subtitle":"","newspack_article_summary_title":"Overview:","newspack_article_summary":"","newspack_hide_updated_date":false,"newspack_show_updated_date":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[7363],"tags":[72,1076,575,7128,427],"brand":[],"newspack_spnsrs_tax":[],"class_list":["post-559603","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ma-watch","tag-enterpriseam","tag-glaxosmithkline","tag-hikma-pharma","tag-ma-watch","tag-pharma","wpautop","entry"],"acf":{"mongo_id":"63329f34-ef75-4d4f-896a-fee755357ece","is_powered_by":true,"story_type":"1","photo_url":"https:\/\/ent.news\/2021\/1\/340.jpg","photo_position":"above","related_issue":[559595],"teaser":"","voice_url":""},"yoast_head":"\nLandmark M&A in pharma, education - EnterpriseAM Egypt<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/enterpriseam.com\/egypt\/2021\/01\/27\/landmark-ma-in-pharma-education\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Landmark M&A in pharma, education\" \/>\n<meta property=\"og:description\" content=\"The week ends with news of two landmark acquisitions, one each in pharma and education. LSE-listed Hikma Pharma plans to buy a 91.2% stake in GlaxoSmithKline\u2019s pharma and manufacturing business in Egypt, according to an EGX disclosure (pdf). The transaction would be subject to the completion of due diligence \u2014 which GSK\u2019s board must now […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/enterpriseam.com\/egypt\/2021\/01\/27\/landmark-ma-in-pharma-education\/\" \/>\n<meta property=\"og:site_name\" content=\"EnterpriseAM Egypt\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-27T03:45:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/i0.wp.com\/ent.news\/2021\/1\/340.jpg?fit=%2C&ssl=1\" \/>\n<meta name=\"author\" content=\"enterpriseam admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"enterpriseam admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2021\/01\/27\/landmark-ma-in-pharma-education\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2021\/01\/27\/landmark-ma-in-pharma-education\/\"},\"author\":{\"name\":\"enterpriseam admin\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\"},\"headline\":\"Landmark M&A in pharma, education\",\"datePublished\":\"2021-01-27T03:45:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2021\/01\/27\/landmark-ma-in-pharma-education\/\"},\"wordCount\":275,\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2021\/01\/27\/landmark-ma-in-pharma-education\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/i0.wp.com\/ent.news\/2021\/1\/340.jpg?fit=%2C&ssl=1\",\"keywords\":[\"EnterpriseAM\",\"GlaxoSmithKline\",\"Hikma Pharma\",\"M&A Watch\",\"pharma\"],\"articleSection\":[\"M&A WATCH\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2021\/01\/27\/landmark-ma-in-pharma-education\/\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/2021\/01\/27\/landmark-ma-in-pharma-education\/\",\"name\":\"Landmark M&A in pharma, education - EnterpriseAM Egypt\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2021\/01\/27\/landmark-ma-in-pharma-education\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2021\/01\/27\/landmark-ma-in-pharma-education\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/i0.wp.com\/ent.news\/2021\/1\/340.jpg?fit=%2C&ssl=1\",\"datePublished\":\"2021-01-27T03:45:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2021\/01\/27\/landmark-ma-in-pharma-education\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/enterpriseam.com\/egypt\/2021\/01\/27\/landmark-ma-in-pharma-education\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2021\/01\/27\/landmark-ma-in-pharma-education\/#primaryimage\",\"url\":\"https:\/\/i0.wp.com\/ent.news\/2021\/1\/340.jpg?fit=%2C&ssl=1\",\"contentUrl\":\"https:\/\/i0.wp.com\/ent.news\/2021\/1\/340.jpg?fit=%2C&ssl=1\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2021\/01\/27\/landmark-ma-in-pharma-education\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/enterpriseam.com\/egypt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Landmark M&A in pharma, education\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"name\":\"EnterpriseAM\",\"description\":\"The State of the Nation\",\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\",\"name\":\"EnterpriseAM\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ent.news\/internal\/240894.svg\",\"contentUrl\":\"https:\/\/ent.news\/internal\/240894.svg\",\"caption\":\"EnterpriseAM\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\",\"name\":\"enterpriseam admin\",\"sameAs\":[\"http:\/\/enterpriseam.testing.projectsarea.com\"],\"url\":\"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Landmark M&A in pharma, education - EnterpriseAM Egypt","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/enterpriseam.com\/egypt\/2021\/01\/27\/landmark-ma-in-pharma-education\/","og_locale":"en_US","og_type":"article","og_title":"Landmark M&A in pharma, education","og_description":"The week ends with news of two landmark acquisitions, one each in pharma and education. LSE-listed Hikma Pharma plans to buy a 91.2% stake in GlaxoSmithKline\u2019s pharma and manufacturing business in Egypt, according to an EGX disclosure (pdf). The transaction would be subject to the completion of due diligence \u2014 which GSK\u2019s board must now […]","og_url":"https:\/\/enterpriseam.com\/egypt\/2021\/01\/27\/landmark-ma-in-pharma-education\/","og_site_name":"EnterpriseAM Egypt","article_published_time":"2021-01-27T03:45:13+00:00","og_image":[{"url":"https:\/\/i0.wp.com\/ent.news\/2021\/1\/340.jpg?fit=%2C&ssl=1","type":"","width":"","height":""}],"author":"enterpriseam admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"enterpriseam admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/enterpriseam.com\/egypt\/2021\/01\/27\/landmark-ma-in-pharma-education\/#article","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/2021\/01\/27\/landmark-ma-in-pharma-education\/"},"author":{"name":"enterpriseam admin","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d"},"headline":"Landmark M&A in pharma, education","datePublished":"2021-01-27T03:45:13+00:00","mainEntityOfPage":{"@id":"https:\/\/enterpriseam.com\/egypt\/2021\/01\/27\/landmark-ma-in-pharma-education\/"},"wordCount":275,"publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"image":{"@id":"https:\/\/enterpriseam.com\/egypt\/2021\/01\/27\/landmark-ma-in-pharma-education\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/ent.news\/2021\/1\/340.jpg?fit=%2C&ssl=1","keywords":["EnterpriseAM","GlaxoSmithKline","Hikma Pharma","M&A Watch","pharma"],"articleSection":["M&A WATCH"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/enterpriseam.com\/egypt\/2021\/01\/27\/landmark-ma-in-pharma-education\/","url":"https:\/\/enterpriseam.com\/egypt\/2021\/01\/27\/landmark-ma-in-pharma-education\/","name":"Landmark M&A in pharma, education - EnterpriseAM Egypt","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/enterpriseam.com\/egypt\/2021\/01\/27\/landmark-ma-in-pharma-education\/#primaryimage"},"image":{"@id":"https:\/\/enterpriseam.com\/egypt\/2021\/01\/27\/landmark-ma-in-pharma-education\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/ent.news\/2021\/1\/340.jpg?fit=%2C&ssl=1","datePublished":"2021-01-27T03:45:13+00:00","breadcrumb":{"@id":"https:\/\/enterpriseam.com\/egypt\/2021\/01\/27\/landmark-ma-in-pharma-education\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/enterpriseam.com\/egypt\/2021\/01\/27\/landmark-ma-in-pharma-education\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/enterpriseam.com\/egypt\/2021\/01\/27\/landmark-ma-in-pharma-education\/#primaryimage","url":"https:\/\/i0.wp.com\/ent.news\/2021\/1\/340.jpg?fit=%2C&ssl=1","contentUrl":"https:\/\/i0.wp.com\/ent.news\/2021\/1\/340.jpg?fit=%2C&ssl=1"},{"@type":"BreadcrumbList","@id":"https:\/\/enterpriseam.com\/egypt\/2021\/01\/27\/landmark-ma-in-pharma-education\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/enterpriseam.com\/egypt\/"},{"@type":"ListItem","position":2,"name":"Landmark M&A in pharma, education"}]},{"@type":"WebSite","@id":"https:\/\/enterpriseam.com\/egypt\/#website","url":"https:\/\/enterpriseam.com\/egypt\/","name":"EnterpriseAM","description":"The State of the Nation","publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/enterpriseam.com\/egypt\/#organization","name":"EnterpriseAM","url":"https:\/\/enterpriseam.com\/egypt\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/","url":"https:\/\/ent.news\/internal\/240894.svg","contentUrl":"https:\/\/ent.news\/internal\/240894.svg","caption":"EnterpriseAM"},"image":{"@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d","name":"enterpriseam admin","sameAs":["http:\/\/enterpriseam.testing.projectsarea.com"],"url":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"}]}},"featured_image_src":"https:\/\/i0.wp.com\/ent.news\/2021\/1\/340.jpg?resize=600%2C400&ssl=1","featured_image_src_square":"https:\/\/i0.wp.com\/ent.news\/2021\/1\/340.jpg?resize=600%2C600&ssl=1","author_info":{"display_name":"enterpriseam admin","author_link":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"},"jetpack_featured_media_url":"https:\/\/i0.wp.com\/ent.news\/2021\/1\/340.jpg?fit=%2C&ssl=1","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":560791,"url":"https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-hikma-end-acquisition-talks\/","url_meta":{"origin":559603,"position":0},"title":"GSK, Hikma end acquisition talks","author":"enterpriseam admin","date":"14 March 2021","format":false,"excerpt":"Hikma Pharma won\u2019t be acquiring GlaxoSmithKline\u2019s Egypt unit: GSK and Hikma Pharma have agreed to end talks over a takeover bid submitted in January by the UK-listed company that would have seen it acquire a majority stake in GSK\u2019s Egypt arm, both companies said (here and here \u2013 pdfs) on\u2026","rel":"","context":"In "M&A WATCH"","block_context":{"text":"M&A WATCH","link":"https:\/\/enterpriseam.com\/egypt\/category\/ma-watch\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2021\/3\/185.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":559931,"url":"https:\/\/enterpriseam.com\/egypt\/2021\/02\/09\/gsk-only-has-eyes-for-hikma\/","url_meta":{"origin":559603,"position":1},"title":"GSK only has eyes for Hikma","author":"enterpriseam admin","date":"9 February 2021","format":false,"excerpt":"GlaxoSmithKline (GSK) has rejected separate takeover bids from Rameda and Acdima for its Egypt arm, focusing instead on talks with Hikma Pharma, according to regulatory filings (here and here \u2014 pdfs). GSK said the decision is meant to minimize disruption to the business and save time and resources that would\u2026","rel":"","context":"In "M&A WATCH"","block_context":{"text":"M&A WATCH","link":"https:\/\/enterpriseam.com\/egypt\/category\/ma-watch\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2021\/2\/153.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":559722,"url":"https:\/\/enterpriseam.com\/egypt\/2021\/02\/02\/a-bidding-war-for-gsks-egyptian-arm\/","url_meta":{"origin":559603,"position":2},"title":"A bidding war for GSK\u2019s Egyptian arm?","author":"enterpriseam admin","date":"2 February 2021","format":false,"excerpt":"Acdima may have just touched off a bidding war for GlaxoSmithKline's Egypt business, according to a regulatory filing (pdf) yesterday, less than a week after the global player revealed that Hikma was interested in a transaction. Acdima, a pharma industry investor focused on Arab countries, plans to make an offer\u2026","rel":"","context":"In "M&A WATCH"","block_context":{"text":"M&A WATCH","link":"https:\/\/enterpriseam.com\/egypt\/category\/ma-watch\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2021\/2\/37.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":565019,"url":"https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-is-staying-put-for-now\/","url_meta":{"origin":559603,"position":3},"title":"GSK is staying put \u2014 for now","author":"enterpriseam admin","date":"14 March 2021","format":false,"excerpt":"GSK puts Egypt exit on the backburner: GlaxoSmithKline has shelved plans to sell its units in Egypt and Tunisia following the breakdown of talks with UK-listed Hikma Pharma, the company said in a disclosure (pdf) to the EGX today. The pharma giant initially wanted to sell its entire 91.2% stake\u2026","rel":"","context":"In "SPEED ROUND: M&A WATCH"","block_context":{"text":"SPEED ROUND: M&A WATCH","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round-ma-watch\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":559757,"url":"https:\/\/enterpriseam.com\/egypt\/2021\/02\/03\/rameda-throws-its-hat-in-the-ring-for-gsks-egypt-business\/","url_meta":{"origin":559603,"position":4},"title":"Rameda throws its hat in the ring for GSK\u2019s Egypt business","author":"enterpriseam admin","date":"3 February 2021","format":false,"excerpt":"Ladies and gentlemen, we have a good, old-fashioned bidding war: Rameda Pharma is the latest to show interest in GlaxoSmithKline's Egypt business, joining LSE-listed Hikma Pharma and pharma industry investor Acdima \u2014 who are both planning their own bids. The company has submitted a non-binding letter of interest to GSK\u2026","rel":"","context":"In "M&A WATCH"","block_context":{"text":"M&A WATCH","link":"https:\/\/enterpriseam.com\/egypt\/category\/ma-watch\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2021\/2\/58.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":560822,"url":"https:\/\/enterpriseam.com\/egypt\/2021\/03\/15\/what-were-tracking-on-15-march-2021\/","url_meta":{"origin":559603,"position":5},"title":"What we\u2019re tracking on 15 March 2021","author":"enterpriseam admin","date":"15 March 2021","format":false,"excerpt":"Good morning, friends, and welcome to another brisk news day in which M&A news takes a back seat to the latest developments in the pandemic and the launch of an EGP 100 bn program to offer 30-year mortgages to low- and middle-income earners with subsidized rates. *** CATCH UP QUICK\u2026","rel":"","context":"In "What We're Tracking Today"","block_context":{"text":"What We're Tracking Today","link":"https:\/\/enterpriseam.com\/egypt\/category\/what-were-tracking-today\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]}],"_links":{"self":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/559603","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/comments?post=559603"}],"version-history":[{"count":0,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/559603\/revisions"}],"acf:post":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/issue\/559595"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/media\/559604"}],"wp:attachment":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/media?parent=559603"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/categories?post=559603"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/tags?post=559603"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/brand?post=559603"},{"taxonomy":"newspack_spnsrs_tax","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/newspack_spnsrs_tax?post=559603"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}